LassmannHBrückWLucchinettiCFThe immunopathology of multiple sclerosis: An overview. Brain Pathol2007; 17: 210–218.
2.
FrischerJMBramowSDal BiancoA. The relation between inflammation and neurodegeneration in multiple sclerosis. Brain2009; 132: 1175–1189.
3.
ReveszTKiddDThompsonAJ. A comparison of the pathology of primary and secondary progressive multiple sclerosis. Brain1994; 117: 759–765.
4.
LucchinettiCFPopescuBFGBunyanRF. Inflammation cortical demyelination in early multiple sclerosis. N Engl J Med2011; 365: 2188–2197.
5.
HowellOWReevesCANicholasR. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain2011; 134: 2755–2771.
6.
ChoiSHowellOWCarassitiD. Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis. Brain2012; 135 (Pt 10): 2925–2937.
7.
HochmeisterSGrundtnerRBauerJ. Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol2006; 65: 855–865.
8.
KutzelniggALucchinettiCFStadelmannC. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain2005; 128: 2705–2712.